ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Human Factors and Usability Engineering in the Development of Drug Delivery Products - Two-Day Workshop Equips Product Developers with Human Factors Testing Skills (September 16-17, 2025) - ResearchAndMarkets.com

The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (ONLINE EVENT: September 16-17, 2025)" has been added to ResearchAndMarkets.com's offering.

This two-day workshop has been designed specifically for product developers who want to incorporate human factors testing into their product development or need to provide the regulators with specific usability data for their device to comply with the MDR.

The format for the day will be interactive with the presenter sharing his experiences as a specialist with extensive knowledge and understanding of the requirements of the MDR, IEC 62366 and FDA human factors Guidance. There will be questions posed for discussion and delegates will work through some of the key aspects of performing a successful human factors study.

Benefits of attending include:

  • Understand the requirements of IEC 62366 and FDA human factors Guidance
  • Know how to provide the regulators with specific usability data for your device
  • Understand human factors and the design process
  • Learn how to validate combination products
  • Consider human factors and risk
  • Discuss generic combination products - ANDAs and HF
  • Find out what HF data FDA require for biosimilars

Certifications:

  • CPD: 12 hours for your records
  • Certificate of completion

Who Should Attend:

This event will be beneficial to those working in the following areas:

  • Engineering and device development
  • Packaging
  • Regulatory affairs
  • Quality systems
  • Quality assurance
  • Risk management
  • Marketing
  • Usability and human factors engineering

Course Agenda

Introduction

  • Scope of the training
  • Expectations for the training

Background to human factors

  • Human factors, usability and ergonomics defined
  • Trends in drug delivery device technology
  • Use errors - scale, scope and implications
  • Defining the user interface
  • Usability research, clinical research and market research compared

Legal and regulatory requirements

  • US law and design control - implications for HF
  • MDR and usability requirements
  • Article 117 and implications for combination products
  • UK medical device regulations

IEC62366, FDA guidance and expectations

  • IEC62366 usability engineering process
  • FDA human factors guidance
  • ISO14971 applied to combination products
  • EMA guidance on combination products
  • Chinese human factors guidance 2022

Human factors methods and best practices

  • Human factors engineering
  • Perception, cognition and action model
  • Heuristic analysis

Design control, design and development

  • Design and development planning
  • Role of human factors in design control
  • UE methods and outputs
  • UE integration with combination product development

User needs & user interface specifications

  • Regulatory requirements for user needs
  • Defining formal user needs
  • User requirements and the design trace matrix
  • Building a user interface specification

Formative and validation testing methods

  • Formative testing methods
  • Human factors validation methods

Use-related risk

  • Regulatory requirements for use-related risk
  • ISO14971 applied to combination products
  • Risk analysis methods
  • Risk control
  • Residual risk analysis

HF and clinical trials

  • How HF and clinical trials differ
  • How to gather HF data during clinical trials
  • Changing the user interface during the trial program
  • HF requirements for INDs and IDEs

Technical data requirements

  • HF contents of a design history file
  • HF contents of a EU technical file

Predicate devices, platform devices and post-market surveillance

  • Platform devices - how to incorporate HF
  • Platform device due diligence
  • Post-market HF requirements - US and EU

Generic devices, biosimilars and ANDAs

  • How to do a database and literature search for known use problems
  • ANDA submissions and HF
  • ANDA versus 505(b)(2) HF requirements
  • FDA HF requirements for biosimilars

Practicalities - how to stay legal

  • GDPR, IRB, HIPAA and the Sunshine Act
  • When to apply for ethics/IRB approval
  • Common GDPR problems during HF testing

Wrap-up

  • Common pitfalls and top tips
  • Top tips

For more information about this training visit https://www.researchandmarkets.com/r/ii02pg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.